Veterinary Diagnostics Market by Technology (PCR, ELISA, Lateral Flow Assay, Molecular Diagnostics, Immunodiagnostics), Product (Consumables, Instruments), Animal (Companion, Livestock, Swine), Application (Infectious, Bacteria) - Global Forecast to 2030

icon1
USD 5.36 BN
MARKET SIZE, 2030
icon2
CAGR 7.8%
(2025-2030)
icon3
580
REPORT PAGES
icon4
775
MARKET TABLES

OVERVIEW

Veterinary Diagnostics Market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The veterinary diagnostics market is projected to reach USD 5.36 billion by 2030 from USD 3.68 billion in 2025, at a CAGR of 7.8% from 2025 to 2030. The veterinary diagnostics market comprises specialized tools, kits, and technologies used to detect, monitor, and prevent diseases in animals. Market growth is fueled by the rising pet ownership and increasing spending on animal healthcare, along with the growing burden of infectious and chronic diseases in companion and livestock populations. In addition, continuous advancements in molecular diagnostics and rapid testing kits are enhancing accuracy and efficiency. The expansion of veterinary clinics and veterinary reference laboratories, coupled with supportive government and regulatory initiatives for animal health management, is further driving adoption. Moreover, the rising demand for early disease detection, preventive healthcare, and point-of-care testing solutions is expected to accelerate market expansion in the coming years.

KEY TAKEAWAYS

  • BY PRODUCT
    The veterinary diagnostics market is divided into consumables and instruments. Consumables like reagents and test kits are widely used for routine and point-of-care testing, while instruments such as analyzers are essential for advanced and accurate disease detection.
  • BY TECHNOLOGY
    The veterinary diagnostics market spans immunodiagnostics, clinical biochemistry, molecular diagnostics, hematology, urinalysis, and other technologies. Immunodiagnostics and clinical biochemistry are widely applied for routine disease detection, while molecular diagnostics enables the precise identification of pathogens. Hematology and urinalysis support monitoring of overall health and metabolic conditions, with other technologies contributing to specialized testing needs.
  • BY ANIMAL TYPE
    Key segments include companion animals and livestock, with demand shaped by rising pet ownership, growing expenditure on companion animal healthcare, and the need for effective disease management in livestock to ensure productivity, food safety, and cost efficiency.
  • BY APPLICATION
    Increasing demand for veterinary diagnostics in infectious diseases, endocrinology, cardiology, oncology, and other applications, driven by the rising prevalence of zoonotic and chronic conditions, greater focus on preventive healthcare, and the need for accurate and early disease detection in companion as well as livestock animals boost growth of the market.
  • BY END USER
    Veterinary reference laboratories lead in demand owing to their advanced infrastructure, high testing volumes, and specialized diagnostic capabilities, followed by veterinary hospitals & clinics, point-of-care/in-house testing, and veterinary research institutes & universities, which are increasingly adopting diagnostics for innovation and preventive healthcare.
  • BY REGION
    The Asia Pacific is expected to register the highest growth rate, at a CAGR of 9.1% driven by rising pet ownership, increasing livestock populations, expanding veterinary infrastructure, and growing investments in animal healthcare across countries like China, India, and Japan.
  • COMPETITIVE LANDSCAPE
    Major market players have adopted both organic and inorganic strategies, including product launches, partnerships, and acquisitions. For instance, leading companies such as IDEXX Laboratories, Inc., Zoetis Services LLC, and Antech Diagnostics, Inc. have expanded their portfolios and entered into collaborations to strengthen their diagnostic offerings and meet the rising demand for advanced veterinary testing solutions.

The veterinary diagnostics market is projected to witness strong growth over the next decade, driven by rising pet ownership, increasing demand for advanced animal healthcare, and continuous innovations in diagnostic technologies. Tools such as immunodiagnostics, molecular tests, and clinical biochemistry analyzers are being increasingly adopted to enable accurate disease detection, timely intervention, and improved treatment outcomes. The growing prevalence of infectious and chronic conditions in both companion and livestock animals, along with the rising emphasis on preventive care, is further fueling adoption. Moreover, the expansion of veterinary clinics and reference laboratories, higher spending on animal health, and the integration of rapid and point-of-care testing solutions are enhancing efficiency and accessibility in veterinary diagnostics. With a growing global animal patient base and heightened focus on early and precise diagnosis, veterinary diagnostics are set to play a pivotal role in shaping the future of animal healthcare delivery.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The impact on the veterinary diagnostics market stems from shifting animal healthcare needs and industry disruptions. Veterinary clinics & hospitals, veterinary reference laboratories, and research institutes form the core customer base for diagnostic solution providers, with applications spanning infectious disease testing, endocrinology, cardiology, and general health monitoring. Trends such as the rising demand for early and accurate disease detection, increasing adoption of point-of-care and digital diagnostic tools, growing focus on preventive healthcare, and stricter regulatory standards are reshaping service providers’ operations and revenues. These changes influence their investment in diagnostic consumables and instruments, thereby directly affecting the growth trajectory and profitability of veterinary diagnostics manufacturers.

Veterinary Diagnostics Market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Growth in companion animal population
  • Increasing demand for animal-derived food products
RESTRAINTS
Impact
Level
  • Rising pet care costs
  • High cost of veterinary diagnostic tests
OPPORTUNITIES
Impact
Level
  • Growth potential of emerging economies
  • Integration of AI and ML
CHALLENGES
Impact
Level
  • Low animal healthcare awareness in emerging economies
  • Shortage of veterinary practitioners in emerging economies

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Growth in companion animal population

The steady growth in the companion animal population is a key driver for the veterinary diagnostics market, as rising pet ownership directly increases the demand for routine health checkups, preventive screening, and early disease detection. With pets increasingly considered family members, owners are more willing to invest in advanced diagnostic tests to ensure better care and longer lifespans. This surge in companion animals, particularly dogs and cats, is fueling higher utilization of diagnostic consumables and instruments, thereby accelerating market growth.

Restraint: Rising pet care costs

Rising pet care costs act as a restraint for the veterinary diagnostics market, as the high expenses associated with advanced diagnostic tests, veterinary visits, and follow-up treatments can limit accessibility for many pet owners. While demand for quality animal healthcare is increasing, the growing financial burden often leads to delayed testing or reduced adoption of advanced diagnostics, particularly in cost-sensitive regions, thereby hindering overall market growth.

Opportunity: Growth potential of emerging economies

The growth potential of emerging economies presents a major opportunity for the veterinary diagnostics market, driven by rising pet ownership, expanding livestock populations, and increasing awareness of animal health. Countries in the Asia Pacific, Latin America, and parts of the Middle East are witnessing rapid improvements in veterinary infrastructure, alongside higher disposable incomes and government initiatives for animal welfare. These factors are creating strong demand for affordable and advanced diagnostic solutions, positioning emerging markets as key growth hubs for global veterinary diagnostics providers.

Challenge: Low animal healthcare awareness in emerging countries

Low awareness of animal healthcare in emerging economies poses a challenge for the veterinary diagnostics market, as limited knowledge about preventive care and early disease detection reduces demand for advanced testing solutions. Many pet owners and livestock farmers prioritize treatment only after visible illness, often neglecting routine diagnostics. This lack of education and awareness slows the adoption of veterinary diagnostic tools, hindering market penetration despite the growing need for improved animal health management.

Veterinary Diagnostics Market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Offers a wide range of in-clinic analyzers such as the Catalyst One Chemistry Analyzer and ProCyte One Hematology Analyzer, along with comprehensive reference laboratory services Rapid and reliable results | Reduced reliance on external labs | Improved treatment outcomes | Enhanced workflow efficiency for clinics
Provides point-of-care diagnostic analyzers for blood chemistry, hematology, and immunoassays through its VETSCAN product line. These systems are designed for small animal, equine, and exotic practices, with cloud-based connectivity for seamless data sharing Faster in-clinic decision-making | Enhanced connectivity with digital platforms | Reliable results across a broad range of species
Provides advanced molecular, histopathology, and genetic testing. Its KeyScreen GI Parasite PCR is a leading solution for comprehensive gastrointestinal parasite detection using molecular diagnostics Highly sensitive detection | Early identification of parasites | Reduced misdiagnosis | Improved preventive care strategies
Offers rapid diagnostic test kits for companion animals and livestock, including solutions for diseases like parvovirus, feline leukemia, and bovine respiratory infections Reliable point-of-care detection | Support for large-scale herd monitoring | Reduced disease transmission risks
Provides advanced in-house veterinary diagnostic analyzers such as the BC-5000Vet Hematology Analyzer and BS-240Vet Chemistry Analyzer, tailored for animal healthcare Cost-effective diagnostics | Quick turnaround | Scalable solutions for different clinic sizes | Robust performance for high sample volumes

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The veterinary diagnostics market ecosystem consists of a network of diagnostic solution manufacturers, distributors, veterinary clinics, hospitals, reference laboratories, and research institutions working collaboratively to provide comprehensive animal healthcare. Manufacturers drive innovation by developing advanced diagnostic instruments, reagents, and test kits, while distributors and suppliers ensure timely availability across regional and global markets. Veterinary professionals are the primary end users, supported by partnerships with research organizations and regulatory bodies that uphold quality, safety, and compliance standards. Additionally, strategic collaborations and investments are expanding access to diagnostic solutions, enabling wider adoption and meeting the growing demand for accurate and timely animal health assessment worldwide.

Veterinary Diagnostics Market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Veterinary Diagnostics Market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Veterinary Diagnostics Market, By Product

By product, consumables hold the largest share of the veterinary diagnostics market because they are used repeatedly in routine testing, including reagents, test kits, and cartridges. Their frequent replacement and wide applicability across multiple diagnostic procedures, from infectious disease screening to hematology and biochemistry tests, drive consistent demand, making consumables a dominant revenue contributor in the market. Additionally, the growing emphasis on preventive care and point-of-care testing further fuels the need for consumables, as these tests require regular use of diagnostic kits and reagents to ensure accurate and timely results.

Veterinary Diagnostics Market, By Technology

The immunodiagnostics segment dominated the overall veterinary diagnostics market in 2024. This technology enables rapid, accurate, and cost-effective detection of a wide range of infectious and chronic diseases in both companion and livestock animals. Its broad applicability across various disease types, ease of use, and suitability for point-of-care and in-house testing make it a preferred choice for veterinary clinics, hospitals, and reference laboratories. Additionally, the growing focus on preventive care and early disease detection further drives the adoption of immunodiagnostic tools, reinforcing their dominant position in the market.

Veterinary Diagnostics Market, By Animal Type

The companion animals segment of the veterinary diagnostics market accounted for the largest share in 2024 because rising pet ownership and increased spending on pet healthcare drive higher demand for diagnostic services. Dogs and cats, in particular, receive regular health checkups, preventive screenings, and early disease detection tests, which require frequent use of diagnostic instruments and consumables. The growing awareness among pet owners about the importance of timely and accurate diagnostics further reinforces the dominance of the companion animals segment in the market.

Veterinary Diagnostics Market, By Application

In the veterinary diagnostics market, infectious diseases hold the largest share because they pose significant risks to both companion and livestock animals, leading to high morbidity and mortality if left undetected. Early and accurate diagnosis of infections such as parvovirus, canine distemper, bovine tuberculosis, and avian influenza is critical for timely treatment and prevention of outbreaks. Growing awareness of zoonotic diseases, rising pet ownership, and the economic impact of livestock infections further drive the demand for reliable infectious disease diagnostic solutions, making this segment the dominant one in the market.

Veterinary Diagnostics Market, By End User

In 2024, veterinary reference laboratories held the largest share of the veterinary diagnostics market because they offer specialized testing services with advanced instruments and high-throughput capabilities that many clinics cannot provide in-house. They cater to both companion animals and livestock, handling complex and routine diagnostic tests, which drives consistent demand for consumables and instruments. Additionally, the increasing focus on accurate, timely, and preventive animal healthcare reinforces the reliance on reference laboratories, making them a dominant segment in the market.

REGION

Asia Pacific to be fastest-growing region in global veterinary diagnostics market during forecast period

The Asia Pacific veterinary diagnostics market is expected to register the highest CAGR in 2024 due to rising pet ownership, expanding livestock populations, and increasing awareness of animal health and preventive care. Rapid improvements in veterinary infrastructure, growing investments in animal healthcare, and supportive government initiatives in countries like China, India, and Japan are driving the adoption of advanced diagnostic technologies. Additionally, the region’s cost-competitive manufacturing and increasing availability of point-of-care solutions further accelerate market growth.

Veterinary Diagnostics Market Region

Veterinary Diagnostics Market: COMPANY EVALUATION MATRIX

In the veterinary diagnostics market matrix, IDEXX Laboratories, Inc. (Star) leads with a strong global presence and a comprehensive portfolio of diagnostic instruments, reagents, and test kits, driving widespread adoption across veterinary clinics, hospitals, and reference laboratories. Shenzhen Mindray Animal Medical Technology Co., Ltd. (Emerging Leader) is gaining traction with innovative diagnostic solutions tailored for veterinary applications, positioning itself for rapid growth. While IDEXX dominates with scale and established market leadership, Mindray demonstrates strong potential to advance toward the leaders' quadrant.

Veterinary Diagnostics Market Evaluation Matrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 3.42 BN
Market Forecast in 2030 (Value) USD 5.36 BN
CAGR CAGR of 7.8% from 2025–2030
Years Considered 2023–2030
Base Year 2024
Forecast Period 2025–2030
Units Considered Value (USD BN), Volume (Thousand Units)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered
  • By Product: Consumables and Instruments
  • By Technology:
    • Immunodiagnostics
    • Clinical Biochemistry
    • Molecular Diagnostics
    • Urinalysis
    • Hematology
    • and Other Technologies
  • By Animal Type: Companion Animals and Livestock
  • By Application:
    • Infectious Diseases
    • Endocrinology
    • Cardiology
    • Oncology
    • and Other Applications
  • By End User:
    • Veterinary Reference Laboratories
    • Veterinary Hospitals & Clinics
    • POC/In-house Testing and Veterinary Research Institutes & Universities
Regional Scope North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

WHAT IS IN IT FOR YOU: Veterinary Diagnostics Market REPORT CONTENT GUIDE

Veterinary Diagnostics Market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Product Analysis Comparison of leading veterinary diagnostics technologies: immunodiagnostics, clinical biochemistry, molecular diagnostics, hematology, urinalysis, and other specialized tests. Immunodiagnostics is witnessing rising adoption for routine and preventive screening, while molecular diagnostics is gaining traction for its accuracy in pathogen detection.
  • Enables identification of technology adoption shifts across veterinary clinics, hospitals, reference laboratories, and research institutes
  • Highlights efficiency, accuracy, and compliance trends influencing purchasing decisions in animal healthcare
Company Information Key players: IDEXX Laboratories, Inc., Zoetis Services LLC, Antech Diagnostics, Inc., Neogen Corporation. Provides insights into competitive strategies, innovation focus (e.g., AI-integrated tools, connected devices), and partnerships or M&A activities shaping the veterinary medical devices and supplies landscape
Geographic Analysis Detailed analysis on the Rest of APAC was provided to one of the top players. Client focused on ASEAN Market country-level analysis for the device market. Country-level demand mapping for new product launches and localization strategy planning

RECENT DEVELOPMENTS

  • June 2025 : bioMérieux introduced VETFIRE, a ready-to-use PCR kit designed specifically for equine infectious respiratory diseases. It enables the simultaneous detection of seven different respiratory pathogens in horses.
  • May 2025 : Zoetis Services LLC inaugurated a new Diagnostics Reference Laboratory at the UPS Healthcare Labport facility that features expanded capacity and improved logistics and is designed to meet the growing demand for veterinary diagnostic services and support more efficient testing and delivery across the region.
  • January 2025 : IDEXX Laboratories, Inc. introduced IDEXX Cancer Dx, a diagnostic panel aimed at the early detection of lymphoma in dogs. This blood test can be incorporated into panels for ill pets and included as part of routine annual wellness screenings.
  • July 2024 : BioNote USA Inc. formed a partnership with MWI Animal Health to distribute its products, including the ycheck line of immunofluorescence assay analyzers. This collaboration is expected to significantly expand BioNote’s reach, enabling wider availability of its diagnostic solutions across veterinary clinics and laboratories.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
47
2
RESEARCH METHODOLOGY
 
 
 
51
3
EXECUTIVE SUMMARY
 
 
 
66
4
PREMIUM INSIGHTS
 
 
 
71
5
MARKET OVERVIEW
Accelerating veterinary market growth driven by tech innovation and rising pet ownership demands.
 
 
 
75
 
5.1
MARKET DYNAMICS
 
 
 
 
 
5.1.1
DRIVERS
 
 
 
 
 
5.1.1.1
GROWTH IN COMPANION ANIMAL POPULATION
 
 
 
 
5.1.1.2
INCREASING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS
 
 
 
 
5.1.1.3
GROWING CONCERNS ABOUT INFECTIOUS ZOONOTIC DISEASES
 
 
 
 
5.1.1.4
RISING DEMAND FOR PET INSURANCE AND GROWING ANIMAL HEALTH EXPENDITURE
 
 
 
 
5.1.1.5
INCREASING NUMBER OF VETERINARY PRACTITIONERS AND RISING INCOME LEVELS IN DEVELOPED MARKETS
 
 
 
 
5.1.1.6
GROWING FOCUS ON DISEASE CONTROL & PREVENTION MEASURES
 
 
 
5.1.2
RESTRAINTS
 
 
 
 
 
5.1.2.1
RISING PET CARE COSTS
 
 
 
 
5.1.2.2
HIGH COST OF VETERINARY DIAGNOSTIC TESTS
 
 
 
5.1.3
OPPORTUNITIES
 
 
 
 
 
5.1.3.1
GROWTH POTENTIAL OF EMERGING ECONOMIES
 
 
 
 
5.1.3.2
INTEGRATION OF AI & ML
 
 
 
5.1.4
CHALLENGES
 
 
 
 
 
5.1.4.1
LOW ANIMAL HEALTHCARE AWARENESS IN EMERGING COUNTRIES
 
 
 
 
5.1.4.2
SHORTAGE OF VETERINARY PRACTITIONERS IN EMERGING ECONOMIES
 
 
5.2
INDUSTRY TRENDS
 
 
 
 
 
5.2.1
ADOPTION OF MULTIPLE TEST PANELS
 
 
 
 
5.2.2
OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES
 
 
 
 
5.2.3
GROWING SCALE OF VETERINARY BUSINESSES
 
 
 
5.3
TECHNOLOGY ANALYSIS
 
 
 
 
 
5.3.1
KEY TECHNOLOGIES
 
 
 
 
 
5.3.1.1
PORTABLE INSTRUMENTS FOR POC DIAGNOSTIC SERVICES
 
 
 
 
5.3.1.2
BIOSENSOR-BASED DIAGNOSTIC SYSTEMS
 
 
 
5.3.2
ADJACENT TECHNOLOGIES
 
 
 
 
 
5.3.2.1
WEARABLE BIOSENSORS & REMOTE MONITORING DEVICES
 
 
 
 
5.3.2.2
DEVELOPMENT OF RAPID & SENSITIVE VETERINARY DIAGNOSTIC KITS
 
 
 
 
5.3.2.3
BREATH & SALIVA-BASED DIAGNOSTIC TOOLS
 
 
 
 
5.3.2.4
MICROFLUIDICS & LAB-ON-CHIP DEVICES
 
 
 
5.3.3
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
5.3.3.1
AI-DRIVEN DIAGNOSTIC PLATFORMS
 
 
 
 
5.3.3.2
NEXT-GENERATION SEQUENCING (NGS)
 
 
5.4
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
5.4.1
THREAT OF NEW ENTRANTS
 
 
 
 
5.4.2
THREAT OF SUBSTITUTES
 
 
 
 
5.4.3
BARGAINING POWER OF SUPPLIERS
 
 
 
 
5.4.4
BARGAINING POWER OF BUYERS
 
 
 
 
5.4.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
5.5
REGULATORY LANDSCAPE
 
 
 
 
 
5.5.1
REGULATORY ANALYSIS
 
 
 
 
5.5.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
5.5.2.1
NORTH AMERICA
 
 
 
 
5.5.2.2
EUROPE
 
 
 
 
5.5.2.3
REST OF THE WORLD
 
 
5.6
PATENT ANALYSIS
 
 
 
 
 
 
5.6.1
PATENT PUBLICATION TRENDS FOR VETERINARY DIAGNOSTICS
 
 
 
 
5.6.2
JURISDICTION & TOP APPLICANT ANALYSIS
 
 
 
5.7
TRADE ANALYSIS
 
 
 
 
 
 
5.7.1
TRADE DATA FOR HS CODE 9018
 
 
 
 
 
5.7.1.1
IMPORT DATA FOR HS CODE 9018
 
 
 
 
5.7.1.2
EXPORT DATA FOR HS CODE 9018
 
 
5.8
PRICING ANALYSIS
 
 
 
 
 
 
5.8.1
AVERAGE SELLING PRICE TREND, BY PRODUCT, 2022–2024
 
 
 
 
 
5.8.1.1
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022–2024
 
 
 
5.8.2
AVERAGE SELLING PRICE, BY REGION
 
 
 
 
 
5.8.2.1
AVERAGE SELLING PRICE OF CLINICAL CHEMISTRY ANALYZERS AND BLOOD GAS & ELECTROLYTE ANALYZERS, BY REGION, 2024
 
 
 
 
5.8.2.2
AVERAGE SELLING PRICE TREND OF CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES, BY REGION, 2022–2024
 
 
 
 
5.8.2.3
AVERAGE SELLING PRICE TREND OF CLINICAL CHEMISTRY ANALYZERS, BY REGION, 2022–2024
 
 
 
 
5.8.2.4
AVERAGE SELLING PRICE TREND OF BLOOD GLUCOSE STRIPS, BY REGION, 2022–2024
 
 
 
 
5.8.2.5
AVERAGE SELLING PRICE TREND OF GLUCOSE MONITORS, BY REGION, 2022–2024
 
 
 
 
5.8.2.6
AVERAGE SELLING PRICE TREND OF BLOOD GAS & ELECTROLYTE REAGENT CLIPS/CARTRIDGES, BY REGION
 
 
 
 
5.8.2.7
AVERAGE SELLING PRICE TREND OF BLOOD GAS & ELECTROLYTE ANALYZERS, BY REGION, 2022–2024
 
 
5.9
REIMBURSEMENT ANALYSIS
 
 
 
 
5.10
KEY CONFERENCES & EVENTS, 2025–2026
 
 
 
 
5.11
KEY STAKEHOLDERS & BUYING CRITERIA
 
 
 
 
 
 
5.11.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
5.11.2
BUYING CRITERIA
 
 
 
5.12
END-USER PERSPECTIVE & UNMET NEEDS
 
 
 
 
5.13
IMPACT OF AI ON VETERINARY DIAGNOSTICS MARKET
 
 
 
 
 
 
5.13.1
INTRODUCTION
 
 
 
 
5.13.2
MARKET POTENTIAL IN VETERINARY DIAGNOSTICS ECOSYSTEM
 
 
 
 
5.13.3
AI-USE CASES
 
 
 
 
5.13.4
KEY COMPANIES IMPLEMENTING AI IN VETERINARY DIAGNOSTICS
 
 
 
5.14
ECOSYSTEM/MARKET MAP
 
 
 
 
 
5.15
VALUE CHAIN ANALYSIS
 
 
 
 
 
5.16
SUPPLY CHAIN ANALYSIS
 
 
 
 
 
5.17
ADJACENT MARKETS
 
 
 
 
5.18
INVESTMENT & FUNDING SCENARIO
 
 
 
 
 
5.19
TRUMP TARIFF IMPACT ON VETERINARY DIAGNOSTICS MARKET
 
 
 
 
 
5.19.1
INTRODUCTION
 
 
 
 
5.19.2
KEY TARIFF RATES
 
 
 
 
5.19.3
PRICE IMPACT ANALYSIS
 
 
 
 
5.19.4
IMPACT ON COUNTRY/REGION
 
 
 
 
5.19.5
IMPACT ON END-USE INDUSTRIES
 
 
6
VETERINARY DIAGNOSTICS MARKET, BY PRODUCT
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 6 Data Tables
 
 
 
123
 
6.1
INTRODUCTION
 
 
 
 
6.2
CONSUMABLES
 
 
 
 
 
6.2.1
RECURRING NATURE TO BOOST DEMAND
 
 
 
6.3
INSTRUMENTS
 
 
 
 
 
6.3.1
INCREASING DEMAND FOR POC ANALYZERS TO DRIVE MARKET
 
 
7
VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Units | 83 Data Tables
 
 
 
130
 
7.1
INTRODUCTION
 
 
 
 
7.2
IMMUNODIAGNOSTICS
 
 
 
 
 
7.2.1
LATERAL FLOW ASSAYS
 
 
 
 
 
7.2.1.1
LATERAL FLOW RAPID TESTS
 
 
 
 
7.2.1.2
LATERAL FLOW STRIP READERS
 
 
 
7.2.2
ELISA
 
 
 
 
 
7.2.2.1
COST-EFFECTIVENESS AND EASE OF USE TO DRIVE MARKET
 
 
 
7.2.3
ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS
 
 
 
 
 
7.2.3.1
INCREASING INCIDENCE OF ALLERGIES IN COMPANION ANIMALS TO FUEL MARKET
 
 
 
7.2.4
IMMUNOASSAY ANALYZERS
 
 
 
 
 
7.2.4.1
HIGH SENSITIVITY & SPECIFICITY FOR BIOMARKER DETECTION TO DRIVE MARKET
 
 
 
7.2.5
RADIOIMMUNOASSAYS
 
 
 
 
 
7.2.5.1
MEASUREMENT OF HORMONE LEVELS AND DETECTION OF SPECIFIC PROTEINS TO FUEL MARKET
 
 
 
7.2.6
OTHER IMMUNODIAGNOSTIC PRODUCTS
 
 
 
7.3
CLINICAL BIOCHEMISTRY
 
 
 
 
 
7.3.1
CLINICAL CHEMISTRY ANALYSIS
 
 
 
 
 
7.3.1.1
CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES
 
 
 
 
7.3.1.2
CLINICAL CHEMISTRY ANALYZERS
 
 
 
7.3.2
GLUCOSE MONITORING
 
 
 
 
 
7.3.2.1
BLOOD GLUCOSE STRIPS
 
 
 
 
7.3.2.2
GLUCOSE MONITORS
 
 
 
 
7.3.2.3
URINE GLUCOSE STRIPS
 
 
 
7.3.3
BLOOD GAS & ELECTROLYTE ANALYSIS
 
 
 
 
 
7.3.3.1
BLOOD GAS & ELECTROLYTE REAGENT CLIPS & CARTRIDGES
 
 
 
 
7.3.3.2
BLOOD GAS & ELECTROLYTE ANALYZERS
 
 
7.4
MOLECULAR DIAGNOSTICS
 
 
 
 
 
7.4.1
PCR TESTS
 
 
 
 
 
7.4.1.1
INCREASED LABORATORY USAGE IN PROTEOMICS & GENOMICS TO SUPPORT GROWTH
 
 
 
7.4.2
MICROARRAYS
 
 
 
 
 
7.4.2.1
GROWING APPLICATIONS OF BIOCHIPS IN IDENTIFYING INFECTIOUS DISEASES TO DRIVE MARKET
 
 
 
7.4.3
NUCLEIC ACID SEQUENCING
 
 
 
 
 
7.4.3.1
IDENTIFICATION OF PATHOGENS TO FUEL MARKET
 
 
 
7.4.4
OTHER MOLECULAR DIAGNOSTIC PRODUCTS
 
 
 
7.5
HEMATOLOGY
 
 
 
 
 
7.5.1
HEMATOLOGY CARTRIDGES
 
 
 
 
 
7.5.1.1
COMPLETE BLOOD ANALYSIS CAPABILITIES TO FUEL MARKET
 
 
 
7.5.2
HEMATOLOGY ANALYZERS
 
 
 
 
 
7.5.2.1
ADOPTION BY VETERINARY HOSPITALS & CLINICS TO SUPPORT MARKET GROWTH
 
 
7.6
URINALYSIS
 
 
 
 
 
7.6.1
URINALYSIS CLIPS & CARTRIDGES/PANELS
 
 
 
 
 
7.6.1.1
DETECTION OF ELECTROLYTES TO BOOST ADOPTION
 
 
 
7.6.2
URINE ANALYZERS
 
 
 
 
 
7.6.2.1
DEVELOPMENT OF ADVANCED ANALYZERS FOR POC TESTING TO SUPPORT MARKET GROWTH
 
 
 
7.6.3
URINE TEST STRIPS
 
 
 
 
 
7.6.3.1
INCREASING PREVALENCE OF CKD IN CATS & DOGS TO DRIVE MARKET
 
 
7.7
OTHER TECHNOLOGIES
 
 
 
8
VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 23 Data Tables
 
 
 
202
 
8.1
INTRODUCTION
 
 
 
 
8.2
COMPANION ANIMALS
 
 
 
 
 
8.2.1
DOGS
 
 
 
 
 
8.2.1.1
HIGH INSURANCE COVERAGE AND AVAILABILITY OF REIMBURSEMENTS TO DRIVE MARKET
 
 
 
8.2.2
CATS
 
 
 
 
 
8.2.2.1
INCREASING PET CAT POPULATION TO SUPPORT MARKET UPTAKE
 
 
 
8.2.3
HORSES
 
 
 
 
 
8.2.3.1
GROWING AWARENESS REGARDING EQUINE HEALTH TO FUEL MARKET
 
 
 
8.2.4
OTHER COMPANION ANIMALS
 
 
 
8.3
LIVESTOCK
 
 
 
 
 
8.3.1
CATTLE
 
 
 
 
 
8.3.1.1
GROWING CONSUMPTION OF DAIRY PRODUCTS TO DRIVE MARKET
 
 
 
8.3.2
PIGS
 
 
 
 
 
8.3.2.1
INCREASING INCIDENCE OF INFECTIOUS DISEASES TO FUEL MARKET
 
 
 
8.3.3
POULTRY
 
 
 
 
 
8.3.3.1
INCREASING DEMAND FOR POULTRY MEAT CONTRIBUTES TO MARKET GROWTH
 
 
 
8.3.4
OTHER LIVESTOCK ANIMALS
 
 
9
VETERINARY DIAGNOSTICS MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 20 Data Tables
 
 
 
225
 
9.1
INTRODUCTION
 
 
 
 
9.2
INFECTIOUS DISEASES
 
 
 
 
 
9.2.1
BACTERIAL INFECTIONS
 
 
 
 
 
9.2.1.1
RAPID SPREAD OF E. COLI TO DRIVE MARKET
 
 
 
9.2.2
VIRAL INFECTIONS
 
 
 
 
 
9.2.2.1
HIGH MUTATION RATE TO ENSURE CONTINUED DEMAND FOR DIAGNOSTICS
 
 
 
9.2.3
PARASITIC INFECTIONS
 
 
 
 
 
9.2.3.1
PRESENCE OF PARASITIC INFECTIONS TO FUEL MARKET
 
 
 
9.2.4
OTHER INFECTIONS
 
 
 
9.3
ENDOCRINOLOGY
 
 
 
 
 
9.3.1
GROWING RISK OF DIABETES TO BOOST DEMAND
 
 
 
9.4
CARDIOLOGY
 
 
 
 
 
9.4.1
INCREASING CASES OF CVD IN DOGS TO FUEL MARKET
 
 
 
9.5
ONCOLOGY
 
 
 
 
 
9.5.1
HIGH INCIDENCE OF CANINE CANCER TO DRIVE MARKET
 
 
 
9.6
OTHER APPLICATIONS
 
 
 
10
VETERINARY DIAGNOSTICS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 6 Data Tables
 
 
 
245
 
10.1
INTRODUCTION
 
 
 
 
10.2
VETERINARY REFERENCE LABORATORIES
 
 
 
 
 
10.2.1
LARGE VOLUME OF TESTING SAMPLES AND AVAILABILITY OF SKILLED WORKFORCE TO PROPEL MARKET
 
 
 
10.3
VETERINARY HOSPITALS & CLINICS
 
 
 
 
 
10.3.1
GROWING PET OWNERSHIP AND SPENDING ON PET CARE TO DRIVE MARKET
 
 
 
10.4
POINT-OF-CARE/IN-HOUSE TESTING
 
 
 
 
 
10.4.1
COST-EFFECTIVENESS AND RAPID RESULTS TO BOOST DEMAND
 
 
 
10.5
VETERINARY RESEARCH INSTITUTES & UNIVERSITIES
 
 
 
 
 
10.5.1
INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND RESEARCH INSTITUTES TO SUPPORT GROWTH
 
 
11
VETERINARY DIAGNOSTICS MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 20 Countries | 537 Data Tables.
 
 
 
254
 
11.1
INTRODUCTION
 
 
 
 
11.2
NORTH AMERICA
 
 
 
 
 
11.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
 
 
 
 
11.2.2
US
 
 
 
 
 
11.2.2.1
HIGH VETERINARY HEALTHCARE EXPENDITURE TO DRIVE MARKET
 
 
 
11.2.3
CANADA
 
 
 
 
 
11.2.3.1
GROWING PET ADOPTION TO DRIVE MARKET
 
 
11.3
EUROPE
 
 
 
 
 
11.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
 
 
 
 
11.3.2
GERMANY
 
 
 
 
 
11.3.2.1
RISING AWARENESS OF ZOONOTIC DISEASES TO FUEL MARKET
 
 
 
11.3.3
UK
 
 
 
 
 
11.3.3.1
INCREASING PET OWNERSHIP TO DRIVE MARKET
 
 
 
11.3.4
FRANCE
 
 
 
 
 
11.3.4.1
WILLINGNESS OF PET OWNERS TO SPEND ON PET HEALTH TO DRIVE MARKET
 
 
 
11.3.5
ITALY
 
 
 
 
 
11.3.5.1
GROWING CONSUMPTION OF MEAT & DAIRY PRODUCTS TO DRIVE MARKET
 
 
 
11.3.6
SPAIN
 
 
 
 
 
11.3.6.1
GROWING DEMAND FOR POULTRY PRODUCTS TO FUEL MARKET
 
 
 
11.3.7
NETHERLANDS
 
 
 
 
 
11.3.7.1
DEVELOPMENTS IN VETERINARY DIAGNOSTIC PRODUCTS TO SUPPORT MARKET GROWTH
 
 
 
11.3.8
REST OF EUROPE
 
 
 
11.4
ASIA PACIFIC
 
 
 
 
 
11.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
 
 
 
 
11.4.2
CHINA
 
 
 
 
 
11.4.2.1
INCREASING INCIDENCE OF ZOONOTIC DISEASES TO PROPEL MARKET
 
 
 
11.4.3
JAPAN
 
 
 
 
 
11.4.3.1
INCREASING PET EXPENDITURE TO SUPPORT MARKET GROWTH
 
 
 
11.4.4
INDIA
 
 
 
 
 
11.4.4.1
INCREASING DEMAND FOR DAIRY PRODUCTS TO DRIVE MARKET
 
 
 
11.4.5
AUSTRALIA
 
 
 
 
 
11.4.5.1
RISE IN PET OWNERSHIP TO SUPPORT MARKET GROWTH
 
 
 
11.4.6
SOUTH KOREA
 
 
 
 
 
11.4.6.1
RISING NEED FOR SPECIALIZED VETERINARY SERVICES TO DRIVE MARKET
 
 
 
11.4.7
NEW ZEALAND
 
 
 
 
 
11.4.7.1
FOCUS ON PET INSURANCE TO AID MARKET
 
 
 
11.4.8
VIETNAM
 
 
 
 
 
11.4.8.1
GROWING FOCUS ON DISEASE SURVEILLANCE TO DRIVE MARKET
 
 
 
11.4.9
REST OF ASIA PACIFIC
 
 
 
11.5
LATIN AMERICA
 
 
 
 
 
11.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
 
 
 
 
11.5.2
BRAZIL
 
 
 
 
 
11.5.2.1
GROWTH IN LIVESTOCK INDUSTRY TO BOOST DEMAND
 
 
 
11.5.3
MEXICO
 
 
 
 
 
11.5.3.1
INCREASING FOCUS ON POULTRY-ASSOCIATED PRODUCTS TO SUPPORT MARKET GROWTH
 
 
 
11.5.4
REST OF LATIN AMERICA
 
 
 
11.6
MIDDLE EAST & AFRICA
 
 
 
 
 
11.6.1
MACROECONOMIC OUTLOOK FOR THE MIDDLE EAST & AFRICA
 
 
 
 
11.6.2
GCC COUNTRIES
 
 
 
 
 
11.6.2.1
KINGDOM OF SAUDI ARABIA (KSA)
 
 
 
 
11.6.2.2
UNITED ARAB EMIRATES (UAE)
 
 
 
 
11.6.2.3
OTHER GCC COUNTRIES
 
 
 
11.6.3
REST OF MIDDLE EAST & AFRICA
 
 
12
COMPETITIVE LANDSCAPE
Uncover market leaders' strategies and financial metrics shaping the competitive landscape.
 
 
 
472
 
12.1
OVERVIEW
 
 
 
 
12.2
KEY PLAYER STRATEGY/RIGHT TO WIN
 
 
 
 
12.3
REVENUE ANALYSIS, 2020–2024
 
 
 
 
 
12.4
MARKET SHARE ANALYSIS
 
 
 
 
 
 
12.4.1
RANKING OF KEY MARKET PLAYERS
 
 
 
12.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
 
 
 
 
 
 
12.5.1
STARS
 
 
 
 
12.5.2
EMERGING LEADERS
 
 
 
 
12.5.3
PERVASIVE PLAYERS
 
 
 
 
12.5.4
PARTICIPANTS
 
 
 
 
12.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
 
 
 
 
 
12.5.5.1
COMPANY FOOTPRINT
 
 
 
 
12.5.5.2
REGION FOOTPRINT
 
 
 
 
12.5.5.3
PRODUCT FOOTPRINT
 
 
 
 
12.5.5.4
TECHNOLOGY FOOTPRINT
 
 
 
 
12.5.5.5
ANIMAL TYPE FOOTPRINT
 
 
12.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
 
 
 
 
 
 
12.6.1
PROGRESSIVE COMPANIES
 
 
 
 
12.6.2
RESPONSIVE COMPANIES
 
 
 
 
12.6.3
DYNAMIC COMPANIES
 
 
 
 
12.6.4
STARTING BLOCKS
 
 
 
 
12.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
 
 
 
 
 
12.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
12.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS
 
 
12.7
BRAND/PRODUCT COMPARATIVE ANALYSIS
 
 
 
 
12.8
R&D EXPENDITURE OF KEY PLAYERS
 
 
 
 
12.9
COMPANY VALUATION & FINANCIAL METRICS
 
 
 
 
 
12.9.1
FINANCIAL METRICS
 
 
 
 
12.9.2
COMPANY VALUATION
 
 
 
12.10
COMPETITIVE SCENARIO
 
 
 
 
 
12.10.1
PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS
 
 
 
 
12.10.2
DEALS
 
 
 
 
12.10.3
EXPANSIONS
 
 
 
 
12.10.4
OTHER DEVELOPMENTS
 
 
13
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
494
 
13.1
KEY PLAYERS
 
 
 
 
 
13.1.1
IDEXX LABORATORIES, INC.
 
 
 
 
 
13.1.1.1
BUSINESS OVERVIEW
 
 
 
 
13.1.1.2
PRODUCTS/SERVICES OFFERED
 
 
 
 
13.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
13.1.1.4
MNM VIEW
 
 
 
13.1.2
ZOETIS SERVICES LLC
 
 
 
 
13.1.3
THERMO FISHER SCIENTIFIC INC.
 
 
 
 
13.1.4
ANTECH DIAGNOSTICS, INC.
 
 
 
 
13.1.5
BIOMÉRIEUX
 
 
 
 
13.1.6
NEOGEN CORPORATION
 
 
 
 
13.1.7
BIO-RAD LABORATORIES, INC.
 
 
 
 
13.1.8
VIRBAC
 
 
 
 
13.1.9
FUJIFILM HOLDINGS CORPORATION
 
 
 
 
13.1.10
SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.
 
 
 
 
13.1.11
INDICAL BIOSCIENCE GMBH
 
 
 
 
13.1.12
BIONOTE
 
 
 
 
13.1.13
BIOGAL
 
 
 
 
13.1.14
AGROLABO S.P.A.
 
 
 
 
13.1.15
INNOVATIVE DIAGNOSTICS
 
 
 
13.2
OTHER PLAYERS
 
 
 
 
 
13.2.1
RANDOX LABORATORIES LTD.
 
 
 
 
13.2.2
BIOCHEK
 
 
 
 
13.2.3
FASSISI, GMBH
 
 
 
 
13.2.4
ALVEDIA
 
 
 
 
13.2.5
SKYER, INC.
 
 
 
 
13.2.6
SHENZHEN BIOEASY BIOTECHNOLOGY, INC.
 
 
 
 
13.2.7
PRECISION BIOSENSOR, INC.
 
 
 
 
13.2.8
EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
 
 
 
 
13.2.9
GOLD STANDARD DIAGNOSTICS
 
 
 
 
13.2.10
SKYLA CORPORATION
 
 
14
APPENDIX
 
 
 
576
 
14.1
DISCUSSION GUIDE
 
 
 
 
14.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
14.3
RELATED REPORTS
 
 
 
 
14.4
AUTHOR DETAILS
 
 
 
LIST OF TABLES
 
 
 
 
 
TABLE 1
STANDARD CURRENCY CONVERSION RATES (USD)
 
 
 
 
TABLE 2
VETERINARY DIAGNOSTICS MARKET: ASSUMPTIONS ANALYSIS
 
 
 
 
TABLE 3
VETERINARY DIAGNOSTICS MARKET: RISK ASSESSMENT ANALYSIS
 
 
 
 
TABLE 4
NUMBER OF US HOUSEHOLDS THAT OWN A PET IN 2024, BY ANIMAL TYPE (MILLIONS)
 
 
 
 
TABLE 5
ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2023)
 
 
 
 
TABLE 6
AVERAGE PREMIUMS PAID IN US, 2020 VS. 2023
 
 
 
 
TABLE 7
NORTH AMERICA: PET HEALTH INSURANCE MARKET (2012–2023) (USD MILLION)
 
 
 
 
TABLE 8
VETERINARY DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
TABLE 9
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 10
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 11
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 12
VETERINARY DIAGNOSTICS MARKET: MAJOR PATENTS
 
 
 
 
TABLE 13
IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2020–2023 (USD THOUSANDS)
 
 
 
 
TABLE 14
EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2023 (USD THOUSANDS)
 
 
 
 
TABLE 15
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022–2024
 
 
 
 
TABLE 16
AVERAGE SELLING PRICE TREND OF CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES, BY REGION, 2022–2024
 
 
 
 
TABLE 17
AVERAGE SELLING PRICE TREND FOR CLINICAL CHEMISTRY ANALYZERS, BY REGION, 2022–2024
 
 
 
 
TABLE 18
AVERAGE SELLING PRICE TREND OF BLOOD GLUCOSE STRIPS, BY REGION, 2022–2024
 
 
 
 
TABLE 19
AVERAGE SELLING PRICE TREND OF GLUCOSE MONITORS, BY REGION, 2022–2024
 
 
 
 
TABLE 20
AVERAGE SELLING PRICE TREND OF BLOOD GAS & ELECTROLYTE REAGENT CLIPS/CARTRIDGES, BY REGION, 2022–2024
 
 
 
 
TABLE 21
AVERAGE SELLING PRICE TREND OF BLOOD GAS & ELECTROLYTE ANALYZERS, BY REGION, 2022–2024
 
 
 
 
TABLE 22
VETERINARY DIAGNOSTICS MARKET: KEY CONFERENCES & EVENTS, 2025–2026
 
 
 
 
TABLE 23
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY DIAGNOSTIC PRODUCTS (%)
 
 
 
 
TABLE 24
KEY COMPANIES IMPLEMENTING AI IN VETERINARY DIAGNOSTICS
 
 
 
 
TABLE 25
VETERINARY DIAGNOSTIC PROVIDERS: ROLE OF COMPANIES IN ECOSYSTEM
 
 
 
 
TABLE 26
US-ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
TABLE 27
KEY PRODUCT-RELATED TARIFFS FOR VETERINARY DIAGNOSTICS
 
 
 
 
TABLE 28
NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS
 
 
 
 
TABLE 29
ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS
 
 
 
 
TABLE 30
EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS
 
 
 
 
TABLE 31
LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS
 
 
 
 
TABLE 32
VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 33
VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 34
KEY PLAYERS OFFERING VETERINARY DIAGNOSTIC CONSUMABLES
 
 
 
 
TABLE 35
VETERINARY DIAGNOSTIC CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 36
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC INSTRUMENTS
 
 
 
 
TABLE 37
VETERINARY DIAGNOSTIC INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 38
VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 39
KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES
 
 
 
 
TABLE 40
VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 41
VETERINARY IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 42
KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS
 
 
 
 
TABLE 43
LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 44
LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 45
KEY PLAYERS PROVIDING LATERAL FLOW RAPID TESTS
 
 
 
 
TABLE 46
LATERAL FLOW RAPID TESTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 47
KEY PLAYERS PROVIDING LATERAL FLOW STRIP READERS
 
 
 
 
TABLE 48
LATERAL FLOW STRIP READERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 49
KEY PLAYERS PROVIDING ELISA TESTS
 
 
 
 
TABLE 50
ELISA MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 51
KEY PLAYERS PROVIDING ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS
 
 
 
 
TABLE 52
ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 53
KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS
 
 
 
 
TABLE 54
IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 55
KEY PLAYERS PROVIDING RADIOIMMUNOASSAYS
 
 
 
 
TABLE 56
RADIOIMMUNOASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 57
KEY PLAYERS PROVIDING OTHER IMMUNODIAGNOSTIC PRODUCTS
 
 
 
 
TABLE 58
OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 59
KEY PLAYERS PROVIDING CLINICAL BIOCHEMISTRY PRODUCTS
 
 
 
 
TABLE 60
VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 61
VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 62
KEY PLAYERS PROVIDING CLINICAL CHEMISTRY ANALYSIS
 
 
 
 
TABLE 63
CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 64
CLINICAL CHEMISTRY ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 65
KEY PLAYERS PROVIDING CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES
 
 
 
 
TABLE 66
CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 67
KEY PLAYERS PROVIDING CLINICAL CHEMISTRY ANALYZERS
 
 
 
 
TABLE 68
CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
 
 
 
 
TABLE 69
CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 70
KEY PLAYERS PROVIDING GLUCOSE MONITORING
 
 
 
 
TABLE 71
GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 72
GLUCOSE MONITORING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 73
KEY PLAYERS PROVIDING BLOOD GLUCOSE STRIPS
 
 
 
 
TABLE 74
BLOOD GLUCOSE STRIPS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
 
 
 
 
TABLE 75
BLOOD GLUCOSE STRIPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 76
KEY PLAYERS PROVIDING GLUCOSE MONITORS
 
 
 
 
TABLE 77
GLUCOSE MONITORS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
 
 
 
 
TABLE 78
GLUCOSE MONITORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 79
KEY PLAYERS PROVIDING URINE GLUCOSE STRIPS
 
 
 
 
TABLE 80
URINE GLUCOSE STRIPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 81
KEY PLAYERS PROVIDING BLOOD GAS & ELECTROLYTE ANALYSIS
 
 
 
 
TABLE 82
BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 83
BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 84
KEY PLAYERS PROVIDING BLOOD GAS & ELECTROLYTE REAGENT CLIPS & CARTRIDGES
 
 
 
 
TABLE 85
BLOOD GAS & ELECTROLYTE REAGENT CLIPS & CARTRIDGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 86
KEY PLAYERS PROVIDING BLOOD GAS & ELECTROLYTE ANALYZERS
 
 
 
 
TABLE 87
BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
 
 
 
 
TABLE 88
BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 89
KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS
 
 
 
 
TABLE 90
VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 91
VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 92
KEY PLAYERS PROVIDING PCR TESTS
 
 
 
 
TABLE 93
PCR TESTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 94
KEY PLAYERS PROVIDING MICROARRAYS
 
 
 
 
TABLE 95
MICROARRAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 96
KEY PLAYERS PROVIDING NUCLEIC ACID SEQUENCING
 
 
 
 
TABLE 97
NUCLEIC ACID SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 98
KEY PLAYERS PROVIDING OTHER MOLECULAR DIAGNOSTIC PRODUCTS
 
 
 
 
TABLE 99
OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 100
KEY PLAYERS PROVIDING HEMATOLOGY PRODUCTS
 
 
 
 
TABLE 101
VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 102
VETERINARY HEMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 103
KEY PLAYERS PROVIDING HEMATOLOGY CARTRIDGES
 
 
 
 
TABLE 104
HEMATOLOGY CARTRIDGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 105
KEY PLAYERS PROVIDING HEMATOLOGY ANALYZERS
 
 
 
 
TABLE 106
HEMATOLOGY ANALYZERS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
 
 
 
 
TABLE 107
HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 108
KEY PLAYERS PROVIDING URINALYSIS PRODUCTS
 
 
 
 
TABLE 109
VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 110
VETERINARY URINALYSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 111
KEY PLAYERS PROVIDING URINALYSIS CLIPS & CARTRIDGES
 
 
 
 
TABLE 112
URINALYSIS CLIPS & CARTRIDGES/PANELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 113
KEY PLAYERS PROVIDING URINE ANALYZERS
 
 
 
 
TABLE 114
URINE ANALYZERS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
 
 
 
 
TABLE 115
URINE ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 116
KEY PLAYERS PROVIDING URINE TEST STRIPS
 
 
 
 
TABLE 117
URINE TEST STRIPS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
 
 
 
 
TABLE 118
URINE TEST STRIPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 119
KEY PLAYERS PROVIDING OTHER VETERINARY DIAGNOSTIC TECHNOLOGIES
 
 
 
 
TABLE 120
OTHER VETERINARY DIAGNOSTIC TECHNOLOGIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 121
VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 122
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR COMPANION ANIMALS
 
 
 
 
TABLE 123
VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 124
VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 125
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR DOGS
 
 
 
 
TABLE 126
VETERINARY DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 127
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR CATS
 
 
 
 
TABLE 128
VETERINARY DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 129
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR HORSES
 
 
 
 
TABLE 130
VETERINARY DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 131
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR OTHER COMPANION ANIMALS
 
 
 
 
TABLE 132
VETERINARY DIAGNOSTICS MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 133
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR LIVESTOCK
 
 
 
 
TABLE 134
VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 135
VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 136
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR CATTLE
 
 
 
 
TABLE 137
VETERINARY DIAGNOSTICS MARKET FOR CATTLE, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 138
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR PIGS
 
 
 
 
TABLE 139
VETERINARY DIAGNOSTICS MARKET FOR PIGS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 140
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR POULTRY
 
 
 
 
TABLE 141
VETERINARY DIAGNOSTICS MARKET FOR POULTRY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 142
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR OTHER LIVESTOCK ANIMALS
 
 
 
 
TABLE 143
VETERINARY DIAGNOSTICS MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 144
VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 145
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR INFECTIOUS DISEASES
 
 
 
 
TABLE 146
VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 147
VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 148
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR BACTERIAL INFECTIONS
 
 
 
 
TABLE 149
VETERINARY DIAGNOSTICS MARKET FOR BACTERIAL INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 150
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR VIRAL INFECTIONS
 
 
 
 
TABLE 151
VETERINARY DIAGNOSTICS MARKET FOR VIRAL INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 152
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR PARASITIC INFECTIONS
 
 
 
 
TABLE 153
VETERINARY DIAGNOSTICS MARKET FOR PARASITIC INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 154
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR OTHER INFECTIONS
 
 
 
 
TABLE 155
VETERINARY DIAGNOSTICS MARKET FOR OTHER INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 156
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR ENDOCRINOLOGY APPLICATIONS
 
 
 
 
TABLE 157
VETERINARY DIAGNOSTICS MARKET FOR ENDOCRINOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 158
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR CARDIOLOGY APPLICATIONS
 
 
 
 
TABLE 159
VETERINARY DIAGNOSTICS MARKET FOR CARDIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 160
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR ONCOLOGY APPLICATIONS
 
 
 
 
TABLE 161
VETERINARY DIAGNOSTICS MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 162
KEY PLAYERS PROVIDING VETERINARY DIAGNOSTICS FOR OTHER APPLICATIONS
 
 
 
 
TABLE 163
VETERINARY DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 164
VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 165
VETERINARY DIAGNOSTICS MARKET FOR VETERINARY REFERENCE LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 166
BASIC ANNUAL EXPENSES FOR CATS & DOGS IN US (2023) (USD)
 
 
 
 
TABLE 167
VETERINARY DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 168
VETERINARY DIAGNOSTICS MARKET FOR POC/IN-HOUSE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 169
VETERINARY DIAGNOSTICS MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 170
VETERINARY DIAGNOSTICS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 171
NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 172
NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 173
NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 174
NORTH AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 175
NORTH AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 176
NORTH AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 177
NORTH AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 178
NORTH AMERICA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 179
NORTH AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 180
NORTH AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 181
NORTH AMERICA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 182
NORTH AMERICA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 183
NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 184
NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 185
NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 186
NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 187
NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 188
NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 189
US: KEY MACRO INDICATORS
 
 
 
 
TABLE 190
US: VETERINARY DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 191
US: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 192
US: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 193
US: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 194
US: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 195
US: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 196
US: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 197
US: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 198
US: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 199
US: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 200
US: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 201
US: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 202
US: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 203
US: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 204
US: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 205
US: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 206
US: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 207
CANADA: KEY MACRO INDICATORS
 
 
 
 
TABLE 208
CANADA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 209
CANADA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 210
CANADA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 211
CANADA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 212
CANADA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 213
CANADA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 214
CANADA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 215
CANADA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 216
CANADA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 217
CANADA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 218
CANADA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 219
CANADA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 220
CANADA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 221
CANADA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 222
CANADA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 223
CANADA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 224
CANADA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 225
EUROPE: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 226
EUROPE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 227
EUROPE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 228
EUROPE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 229
EUROPE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 230
EUROPE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 231
EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 232
EUROPE: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 233
EUROPE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 234
EUROPE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 235
EUROPE: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 236
EUROPE: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 237
EUROPE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 238
EUROPE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 239
EUROPE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 240
EUROPE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 241
EUROPE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 242
EUROPE: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 243
GERMANY: KEY MACRO INDICATORS
 
 
 
 
TABLE 244
GERMANY: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 245
GERMANY: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 246
GERMANY: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 247
GERMANY: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 248
GERMANY: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 249
GERMANY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 250
GERMANY: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 251
GERMANY: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 252
GERMANY: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 253
GERMANY: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 254
GERMANY: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 255
GERMANY: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 256
GERMANY: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 257
GERMANY: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 258
GERMANY: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 259
GERMANY: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 260
GERMANY: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 261
UK: KEY MACRO INDICATORS
 
 
 
 
TABLE 262
UK: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 263
UK: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 264
UK: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 265
UK: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 266
UK: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 267
UK: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 268
UK: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 269
UK: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 270
UK: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 271
UK: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 272
UK: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 273
UK: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 274
UK: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 275
UK: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 276
UK: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 277
UK: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 278
UK: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 279
FRANCE: KEY MACRO INDICATORS
 
 
 
 
TABLE 280
FRANCE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 281
FRANCE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 282
FRANCE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 283
FRANCE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 284
FRANCE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 285
FRANCE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 286
FRANCE: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 287
FRANCE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 288
FRANCE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 289
FRANCE: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 290
FRANCE: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 291
FRANCE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 292
FRANCE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 293
FRANCE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 294
FRANCE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 295
FRANCE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 296
FRANCE: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 297
ITALY: KEY MACRO INDICATORS
 
 
 
 
TABLE 298
ITALY: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 299
ITALY: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 300
ITALY: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 301
ITALY: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 302
ITALY: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 303
ITALY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 304
ITALY: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 305
ITALY: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 306
ITALY: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 307
ITALY: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 308
ITALY: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 309
ITALY: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 310
ITALY: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 311
ITALY: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 312
ITALY: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 313
ITALY: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 314
ITALY: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 315
SPAIN: KEY MACRO INDICATORS
 
 
 
 
TABLE 316
SPAIN: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 317
SPAIN: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 318
SPAIN: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 319
SPAIN: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 320
SPAIN: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 321
SPAIN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 322
SPAIN: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 323
SPAIN: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 324
SPAIN: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 325
SPAIN: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 326
SPAIN: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 327
SPAIN: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 328
SPAIN: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 329
SPAIN: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 330
SPAIN: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 331
SPAIN: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 332
SPAIN: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 333
NETHERLANDS: KEY MACRO INDICATORS
 
 
 
 
TABLE 334
NETHERLANDS: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 335
NETHERLANDS: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 336
NETHERLANDS: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 337
NETHERLANDS: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 338
NETHERLANDS: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 339
NETHERLANDS: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 340
NETHERLANDS: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 341
NETHERLANDS: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 342
NETHERLANDS: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 343
NETHERLANDS: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 344
NETHERLANDS: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 345
NETHERLANDS: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 346
NETHERLANDS: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 347
NETHERLANDS: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 348
NETHERLANDS: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 349
NETHERLANDS: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 350
NETHERLANDS: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 351
REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 352
REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 353
REST OF EUROPE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 354
REST OF EUROPE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 355
REST OF EUROPE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 356
REST OF EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 357
REST OF EUROPE: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 358
REST OF EUROPE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 359
REST OF EUROPE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 360
REST OF EUROPE: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 361
REST OF EUROPE: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 362
REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 363
REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 364
REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 365
REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 366
REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 367
REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 368
ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 369
ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 370
ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 371
ASIA PACIFIC: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 372
ASIA PACIFIC: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 373
ASIA PACIFIC: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 374
ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 375
ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 376
ASIA PACIFIC: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 377
ASIA PACIFIC: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 378
ASIA PACIFIC: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 379
ASIA PACIFIC: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 380
ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 381
ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 382
ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 383
ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 384
ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 385
ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 386
CHINA: KEY MACRO INDICATORS
 
 
 
 
TABLE 387
CHINA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 388
CHINA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 389
CHINA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 390
CHINA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 391
CHINA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 392
CHINA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 393
CHINA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 394
CHINA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 395
CHINA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 396
CHINA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 397
CHINA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 398
CHINA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 399
CHINA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 400
CHINA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 401
CHINA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 402
CHINA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 403
CHINA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 404
JAPAN: KEY MACRO INDICATORS
 
 
 
 
TABLE 405
JAPAN: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 406
JAPAN: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 407
JAPAN: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 408
JAPAN: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 409
JAPAN: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 410
JAPAN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 411
JAPAN: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 412
JAPAN: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 413
JAPAN: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 414
JAPAN: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 415
JAPAN: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 416
JAPAN: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 417
JAPAN: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 418
JAPAN: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 419
JAPAN: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 420
JAPAN: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 421
JAPAN: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 422
INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS)
 
 
 
 
TABLE 423
INDIA: KEY MACRO INDICATORS
 
 
 
 
TABLE 424
INDIA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 425
INDIA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 426
INDIA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 427
INDIA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 428
INDIA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 429
INDIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 430
INDIA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 431
INDIA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 432
INDIA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 433
INDIA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 434
INDIA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 435
INDIA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 436
INDIA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 437
INDIA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 438
INDIA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 439
INDIA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 440
INDIA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 441
AUSTRALIA: KEY MACRO INDICATORS
 
 
 
 
TABLE 442
AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 443
AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 444
AUSTRALIA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 445
AUSTRALIA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 446
AUSTRALIA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 447
AUSTRALIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 448
AUSTRALIA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 449
AUSTRALIA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 450
AUSTRALIA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 451
AUSTRALIA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 452
AUSTRALIA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 453
AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 454
AUSTRALIA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 455
AUSTRALIA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 456
AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 457
AUSTRALIA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 458
AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 459
SOUTH KOREA: KEY MACRO INDICATORS
 
 
 
 
TABLE 460
SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 461
SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 462
SOUTH KOREA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 463
SOUTH KOREA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 464
SOUTH KOREA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 465
SOUTH KOREA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 466
SOUTH KOREA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 467
SOUTH KOREA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 468
SOUTH KOREA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 469
SOUTH KOREA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 470
SOUTH KOREA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 471
SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 472
SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 473
SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 474
SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 475
SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 476
SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 477
NEW ZEALAND: KEY MACRO INDICATORS
 
 
 
 
TABLE 478
NEW ZEALAND: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 479
NEW ZEALAND: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 480
NEW ZEALAND: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 481
NEW ZEALAND: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 482
NEW ZEALAND: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 483
NEW ZEALAND: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 484
NEW ZEALAND: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 485
NEW ZEALAND: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 486
NEW ZEALAND: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 487
NEW ZEALAND: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 488
NEW ZEALAND: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 489
NEW ZEALAND: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 490
NEW ZEALAND: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 491
NEW ZEALAND: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 492
NEW ZEALAND: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 493
NEW ZEALAND: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 494
NEW ZEALAND: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 495
VIETNAM: KEY MACRO INDICATORS
 
 
 
 
TABLE 496
VIETNAM: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 497
VIETNAM: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 498
VIETNAM: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 499
VIETNAM: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 500
VIETNAM: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 501
VIETNAM: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 502
VIETNAM: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 503
VIETNAM: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 504
VIETNAM: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 505
VIETNAM: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 506
VIETNAM: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 507
VIETNAM: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 508
VIETNAM: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 509
VIETNAM: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 510
VIETNAM: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 511
VIETNAM: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 512
VIETNAM: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 513
REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 514
REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 515
REST OF ASIA PACIFIC: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 516
REST OF ASIA PACIFIC: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 517
REST OF ASIA PACIFIC: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 518
REST OF ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 519
REST OF ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 520
REST OF ASIA PACIFIC: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 521
REST OF ASIA PACIFIC: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 522
REST OF ASIA PACIFIC: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 523
REST OF ASIA PACIFIC: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 524
REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 525
REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 526
REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 527
REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 528
REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 529
REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 530
LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 531
LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 532
LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 533
LATIN AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 534
LATIN AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 535
LATIN AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 536
LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 537
LATIN AMERICA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 538
LATIN AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 539
LATIN AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 540
LATIN AMERICA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 541
LATIN AMERICA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 542
LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 543
LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 544
LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 545
LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 546
LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 547
LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 548
BRAZIL: KEY MACRO INDICATORS
 
 
 
 
TABLE 549
BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 550
BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 551
BRAZIL: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 552
BRAZIL: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 553
BRAZIL: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 554
BRAZIL: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 555
BRAZIL: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 556
BRAZIL: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 557
BRAZIL: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 558
BRAZIL: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 559
BRAZIL: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 560
BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 561
BRAZIL: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 562
BRAZIL: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 563
BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 564
BRAZIL: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 565
BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 566
MEXICO: KEY MACRO INDICATORS
 
 
 
 
TABLE 567
MEXICO: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 568
MEXICO: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030(USD MILLION)
 
 
 
 
TABLE 569
MEXICO: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 570
MEXICO: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 571
MEXICO: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 572
MEXICO: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 573
MEXICO: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 574
MEXICO: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 575
MEXICO: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 576
MEXICO: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 577
MEXICO: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 578
MEXICO: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 579
MEXICO: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 580
MEXICO: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 581
MEXICO: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 582
MEXICO: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 583
MEXICO: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 584
REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 585
REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 586
REST OF LATIN AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 587
REST OF LATIN AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 588
REST OF LATIN AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 589
REST OF LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 590
REST OF LATIN AMERICA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 591
REST OF LATIN AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 592
REST OF LATIN AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 593
REST OF LATIN AMERICA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 594
REST OF LATIN AMERICA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 595
REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 596
REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 597
REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 598
REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 599
REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 600
REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 601
MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 602
MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 603
MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 604
MIDDLE EAST & AFRICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 605
MIDDLE EAST & AFRICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 606
MIDDLE EAST & AFRICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 607
MIDDLE EAST & AFRICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 608
MIDDLE EAST & AFRICA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 609
MIDDLE EAST & AFRICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 610
MIDDLE EAST & AFRICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 611
MIDDLE EAST & AFRICA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 612
MIDDLE EAST & AFRICA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 613
MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 614
MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 615
MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 616
MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 617
MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 618
MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 619
GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 620
GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 621
GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 622
GCC COUNTRIES: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 623
GCC COUNTRIES: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 624
GCC COUNTRIES: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 625
GCC COUNTRIES: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 626
GCC COUNTRIES: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 627
GCC COUNTRIES: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 628
GCC COUNTRIES: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 629
GCC COUNTRIES: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 630
GCC COUNTRIES: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 631
GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 632
GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 633
GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 634
GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 635
GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 636
GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 637
KINGDOM OF SAUDI ARABIA: KEY MACRO INDICATORS
 
 
 
 
TABLE 638
KINGDOM OF SAUDI ARABIA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 639
KINGDOM OF SAUDI ARABIA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 640
KINGDOM OF SAUDI ARABIA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 641
KINGDOM OF SAUDI ARABIA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 642
KINGDOM OF SAUDI ARABIA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 643
KINGDOM OF SAUDI ARABIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 644
KINGDOM OF SAUDI ARABIA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 645
KINGDOM OF SAUDI ARABIA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 646
KINGDOM OF SAUDI ARABIA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 647
KINGDOM OF SAUDI ARABIA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 648
KINGDOM OF SAUDI ARABIA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 649
KINGDOM OF SAUDI ARABIA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 650
KINGDOM OF SAUDI ARABIA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 651
KINGDOM OF SAUDI ARABIA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 652
KINGDOM OF SAUDI ARABIA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 653
KINGDOM OF SAUDI ARABIA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 654
KINGDOM OF SAUDI ARABIA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 655
UNITED ARAB EMIRATES: KEY MACRO INDICATORS
 
 
 
 
TABLE 656
UNITED ARAB EMIRATES: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 657
UNITED ARAB EMIRATES: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 658
UNITED ARAB EMIRATES: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 659
UNITED ARAB EMIRATES: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 660
UNITED ARAB EMIRATES: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 661
UNITED ARAB EMIRATES: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 662
UNITED ARAB EMIRATES: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 663
UNITED ARAB EMIRATES: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 664
UNITED ARAB EMIRATES: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 665
UNITED ARAB EMIRATES: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 666
UNITED ARAB EMIRATES: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 667
UNITED ARAB EMIRATES: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 668
UNITED ARAB EMIRATES: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 669
UNITED ARAB EMIRATES: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 670
UNITED ARAB EMIRATES: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 671
UNITED ARAB EMIRATES: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 672
UNITED ARAB EMIRATES: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 673
OTHER GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 674
OTHER GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 675
OTHER GCC COUNTRIES: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 676
OTHER GCC COUNTRIES: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 677
OTHER GCC COUNTRIES: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 678
OTHER GCC COUNTRIES: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 679
OTHER GCC COUNTRIES: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 680
OTHER GCC COUNTRIES: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 681
OTHER GCC COUNTRIES: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 682
OTHER GCC COUNTRIES: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 683
OTHER GCC COUNTRIES: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 684
OTHER GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 685
OTHER GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 686
OTHER GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 687
OTHER GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 688
OTHER GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 689
OTHER GCC COUNTRIES: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 690
REST OF MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 691
REST OF MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 692
REST OF MIDDLE EAST & AFRICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 693
REST OF MIDDLE EAST & AFRICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 694
REST OF MIDDLE EAST & AFRICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 695
REST OF MIDDLE EAST & AFRICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 696
REST OF MIDDLE EAST & AFRICA: GLUCOSE MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 697
REST OF MIDDLE EAST & AFRICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 698
REST OF MIDDLE EAST & AFRICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 699
REST OF MIDDLE EAST & AFRICA: VETERINARY HEMATOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 700
REST OF MIDDLE EAST & AFRICA: VETERINARY URINALYSIS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 701
REST OF MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 702
REST OF MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 703
REST OF MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 704
REST OF MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 705
REST OF MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 706
REST OF MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 707
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY DIAGNOSTICS MARKET
 
 
 
 
TABLE 708
VETERINARY DIAGNOSTICS MARKET: DEGREE OF COMPETITION
 
 
 
 
TABLE 709
VETERINARY DIAGNOSTICS MARKET: REGION FOOTPRINT
 
 
 
 
TABLE 710
VETERINARY DIAGNOSTIC MARKET: PRODUCT FOOTPRINT
 
 
 
 
TABLE 711
VETERINARY DIAGNOSTICS MARKET: TECHNOLOGY FOOTPRINT
 
 
 
 
TABLE 712
VETERINARY DIAGNOSTIC MARKET: ANIMAL TYPE FOOTPRINT
 
 
 
 
TABLE 713
VETERINARY DIAGNOSTIC MARKET: DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
TABLE 714
VETERINARY DIAGNOSTIC MARKET: COMPETITIVE BENCHMARKING OF STARTUPS
 
 
 
 
TABLE 715
VETERINARY DIAGNOSTIC MARKET: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 716
VETERINARY DIAGNOSTICS MARKET: DEALS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 717
VETERINARY DIAGNOSTICS MARKET: EXPANSIONS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 718
VETERINARY DIAGNOSTIC MARKET: OTHER DEVELOPMENTS, JANUARY 2022-MARCH 2025
 
 
 
 
TABLE 719
IDEXX LABORATORIES, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 720
IDEXX LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 721
IDEXX LABORATORIES, INC.: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 722
ZOETIS SERVICES LLC: COMPANY OVERVIEW
 
 
 
 
TABLE 723
ZOETIS SERVICES LLC: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 724
ZOETIS SERVICES LLC: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 725
ZOETIS SERVICES LLC: DEALS, JANUARY 2022–APRIL 2025
 
 
 
 
TABLE 726
ZOETIS SERVICES LLC: EXPANSIONS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 727
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 728
THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 729
ANTECH DIAGNOSTICS, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 730
ANTECH DIAGNOSTICS, INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 731
ANTECH DIAGNOSTICS, INC.: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 732
ANTECH DIAGNOSTICS, INC.: EXPANSIONS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 733
BIOMÉRIEUX: COMPANY OVERVIEW
 
 
 
 
TABLE 734
BIOMÉRIEUX: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 735
BIOMÉRIEUX: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 736
NEOGEN CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 737
NEOGEN CORPORATION: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 738
NEOGEN CORPORATION: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 739
NEOGEN CORPORATION: DEALS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 740
NEOGEN CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 741
BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 742
BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 743
VIRBAC: COMPANY OVERVIEW
 
 
 
 
TABLE 744
VIRBAC: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 745
VIRBAC: DEALS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 746
VIRBAC: EXPANSIONS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 747
FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 748
FUJIFILM HOLDINGS CORPORATION: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 749
SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
 
 
 
 
TABLE 750
SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 751
SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 752
SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: EXPANSIONS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 753
INDICAL BIOSCIENCE GMBH: COMPANY OVERVIEW
 
 
 
 
TABLE 754
INDICAL BIOSCIENCE: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 755
INDICAL BIOSCIENCE GMBH: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 756
BIONOTE: COMPANY OVERVIEW
 
 
 
 
TABLE 757
BIONOTE: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 758
BIONOTE: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 759
BIONOTE: DEALS, JANUARY 2022–MAY 2025
 
 
 
 
TABLE 760
BIOGAL: COMPANY OVERVIEW
 
 
 
 
TABLE 761
BIOGAL: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 762
AGROLABO S.P.A.: COMPANY OVERVIEW
 
 
 
 
TABLE 763
AGROLABO S.P.A.: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 764
INNOVATIVE DIAGNOSTICS: COMPANY OVERVIEW
 
 
 
 
TABLE 765
INNOVATIVE DIAGNOSTICS: PRODUCTS/SERVICES OFFERED
 
 
 
 
TABLE 766
RANDOX LABORATORIES LTD.: COMPANY OVERVIEW
 
 
 
 
TABLE 767
BIOCHEK: COMPANY OVERVIEW
 
 
 
 
TABLE 768
FASSISI, GMBH: COMPANY OVERVIEW
 
 
 
 
TABLE 769
ALVEDIA: COMPANY OVERVIEW
 
 
 
 
TABLE 770
SKYER, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 771
SHENZHEN BIOEASY BIOTECHNOLOGY, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 772
PRECISION BIOSENSOR, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 773
EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG: COMPANY OVERVIEW
 
 
 
 
TABLE 774
GOLD STANDARD DIAGNOSTICS: COMPANY OVERVIEW
 
 
 
 
TABLE 775
SKYLA CORPORATION: COMPANY OVERVIEW
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
FIGURE 1
VETERINARY DIAGNOSTICS MARKET SEGMENTATION & REGIONAL SPREAD
 
 
 
 
FIGURE 2
VETERINARY DIAGNOSTICS MARKET: RESEARCH DESIGN
 
 
 
 
FIGURE 3
PRIMARY SOURCES
 
 
 
 
FIGURE 4
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE)
 
 
 
 
FIGURE 5
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (DEMAND SIDE)
 
 
 
 
FIGURE 6
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
 
 
 
 
FIGURE 7
SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
 
 
 
 
FIGURE 8
REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.
 
 
 
 
FIGURE 9
REVENUE ANALYSIS OF TOP FIVE COMPANIES: VETERINARY DIAGNOSTICS MARKET (2024)
 
 
 
 
FIGURE 10
VETERINARY DIAGNOSTICS MARKET: DEMAND-SIDE ANALYSIS
 
 
 
 
FIGURE 11
CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VETERINARY DIAGNOSTICS MARKET (2025–2030)
 
 
 
 
FIGURE 12
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
 
 
 
 
FIGURE 13
TOP-DOWN APPROACH
 
 
 
 
FIGURE 14
BOTTOM-UP APPROACH
 
 
 
 
FIGURE 15
MARKET DATA TRIANGULATION METHODOLOGY
 
 
 
 
FIGURE 16
VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 17
VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 18
VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 19
VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 20
VETERINARY DIAGNOSTICS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 21
GEOGRAPHIC SNAPSHOT OF VETERINARY DIAGNOSTICS MARKET
 
 
 
 
FIGURE 22
GROWING PREVALENCE OF ZOONOTIC DISEASES TO PROPEL MARKET
 
 
 
 
FIGURE 23
CONSUMABLES SEGMENT IN CHINA ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
 
 
 
 
FIGURE 24
ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
 
 
 
 
FIGURE 25
CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
 
 
 
 
FIGURE 26
EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
 
 
 
 
FIGURE 27
VETERINARY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
FIGURE 28
EUROPE: PET POPULATION, 2021–2023
 
 
 
 
FIGURE 29
US: PET EXPENDITURE, DOGS VS CATS, 2024 (USD)
 
 
 
 
FIGURE 30
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
FIGURE 31
VETERINARY DIAGNOSTICS MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2014–MAY 2025)
 
 
 
 
FIGURE 32
TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY DIAGNOSTIC PATENTS (JANUARY 2014–MAY 2025)
 
 
 
 
FIGURE 33
AVERAGE SELLING PRICE TREND FOR CLINICAL CHEMISTRY AND BLOOD GAS & ELECTROLYTE ANALYZERS, BY KEY PLAYER, 2024
 
 
 
 
FIGURE 34
AVERAGE SELLING PRICE FOR CLINICAL CHEMISTRY ANALYZERS AND BLOOD GAS & ELECTROLYTE ANALYZERS, BY REGION, 2024
 
 
 
 
FIGURE 35
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY DIAGNOSTICS
 
 
 
 
FIGURE 36
KEY BUYING CRITERIA FOR TOP THREE END USERS
 
 
 
 
FIGURE 37
AI-USE CASES
 
 
 
 
FIGURE 38
VETERINARY DIAGNOSTICS MARKET: ECOSYSTEM MARKET MAP
 
 
 
 
FIGURE 39
VETERINARY DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
FIGURE 40
VETERINARY DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS
 
 
 
 
FIGURE 41
VETERINARY DIAGNOSTICS MARKET: ADJACENT MARKETS
 
 
 
 
FIGURE 42
VETERINARY DIAGNOSTICS MARKET: GEOGRAPHIC SNAPSHOT
 
 
 
 
FIGURE 43
EXPECTED GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA
 
 
 
 
FIGURE 44
NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET SNAPSHOT
 
 
 
 
FIGURE 45
ASIA PACIFIC: DOG POPULATION GROWTH, BY COUNTRY, 2024
 
 
 
 
FIGURE 46
ASIA PACIFIC: CAT POPULATION GROWTH, BY COUNTRY, 2024
 
 
 
 
FIGURE 47
ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET SNAPSHOT
 
 
 
 
FIGURE 48
REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY DIAGNOSTICS MARKET (2022–2024)
 
 
 
 
FIGURE 49
MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY DIAGNOSTICS MARKET (2024)
 
 
 
 
FIGURE 50
RANKING OF KEY PLAYERS IN VETERINARY DIAGNOSTICS MARKET, 2024
 
 
 
 
FIGURE 51
VETERINARY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX, 2024
 
 
 
 
FIGURE 52
VETERINARY DIAGNOSTICS MARKET: COMPANY FOOTPRINT
 
 
 
 
FIGURE 53
VETERINARY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
 
 
 
 
FIGURE 54
VETERINARY DIAGNOSTICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
 
 
 
 
FIGURE 55
R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY DIAGNOSTICS MARKET, 2022–2024
 
 
 
 
FIGURE 56
EV/EBITDA OF KEY VENDORS
 
 
 
 
FIGURE 57
YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
FIGURE 58
IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 59
ZOETIS SERVICES LLC: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 60
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 61
BIOMÉRIEUX: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 62
NEOGEN CORPORATION: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 63
BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 64
VIRBAC: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 65
FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 66
SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: COMPANY SNAPSHOT (2024)
 
 
 
 

Methodology

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

Secondary Research

This research study used widespread secondary sources; directories, databases such as Dun & Bradstreet, Bloomberg BusinessWeek, and Factiva; white papers; annual reports; and companies’ house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the global pulse oximeters market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends, to the bottom-most level, geographic markets, and key developments related to the market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the veterinary diagnostic market. Primary sources from the demand side include veterinary healthcare professionals from hospitals, clinics, reference laboratories, and research institutes.

A breakdown of the primary respondents is provided below:

Veterinary Diagnostics Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The research methodology used to estimate the size of the veterinary diagnostics market includes the following details.

The market sizing was undertaken from the global side.

Country-level Analysis: The size of the veterinary diagnostics market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products and services in the overall veterinary diagnostics market was obtained from secondary data and validated by primary participants to arrive at the total veterinary diagnostics market. Primary participants further validated the numbers.

Geographic market assessment (by region & country): The geographic evaluation was done using the following approaches:

Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

At each point, industry experts contacted during primary research validated the assumptions and approaches. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall veterinary diagnostics market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

Global Veterinary Diagnostics Market Size: Top-Down & Bottom-Up Approach

 

Veterinary Diagnostics Market

Data Triangulation

After arriving at the overall size from the market size estimation process explained above, the total market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures described below were implemented to complete the overall market engineering process and arrive at the exact statistics for various market segments and subsegments. The data was triangulated by studying different factors and trends from the demand and supply sides. The market size was also validated using both the top-down and bottom-up approaches.

Market Definition

Veterinary diagnostics refers to the diagnosis of animal diseases and disorders using various veterinary diagnostic test kits, tools, and instruments such as clinical chemistry analyzers, hematology analyzers, glucose monitoring systems, urine analyzers, blood gas-electrolyte analyzers, and ELISA test kits.

The veterinarian mainly orders veterinary diagnostic tests to identify parasites, bacteria, viruses, and other disease-causing microbes in companion animals or livestock. Improvements in consumables enable precise detection despite limitations observed by other tests. For instance, a diagnostic test using a new, improved fecal detection test kit by IDEXX Laboratories eliminates the limitations of egg shedding identification. It reduces false-positive cases when diagnosing hookworm antigens in the companion animal intestine. Thus, veterinary diagnostic tests are ordered for all kinds of ailments to enable effective detection and help in treatment planning and decision making by the veterinarian and the companion animal owner.

Stakeholders

  • Senior Management
  • Veterinary Diagnostic Companies
  • Veterinary Clinics & Hospitals
  • Pet Owners and Livestock Farmers
  • Reference Laboratories
  • Veterinarians & Veterinary Technicians
  • Animal Health Organizations and NGOs
  • Regulatory Authorities
  • Research Institutes & Universities
  • Distributors & Supply Chain Partners
  • Investors & Strategic Partners

Report Objectives

  • To define, describe, and forecast the veterinary diagnostics market by product, technology, animal type, application, end user, and region.
  • To provide detailed information about the key factors influencing market growth, such as drivers, restraints, opportunities, challenges, and industry trends
  • To strategically analyze the regulatory scenario, Porter’s five forces analysis, value chain analysis, supply chain analysis, ecosystem map, recession impact, and patent analysis
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall veterinary diagnostics market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
  • To strategically profile the key players in this market and comprehensively analyze their market shares and core competencies.
  • To strategically analyze the veterinary diagnostics market in five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To track & analyze competitive developments such as acquisitions, product launches, partnerships, and expansions in the veterinary diagnostics market.

 

Key Questions Addressed by the Report

Who are the leading industry players in the veterinary diagnostics market?

The prominent players in the veterinary diagnostics market include IDEXX Laboratories, Inc. (US), Zoetis Services LLC (US), Thermo Fisher Scientific Inc. (US), Antech Diagnostics, Inc. (US), and bioMérieux (France).

Which geographic region is expected to grow at the highest CAGR in the veterinary diagnostics market?

The Asia Pacific region is projected to grow at the highest CAGR during the forecast period.

Which technology segment is expected to dominate the market during the forecast period?

The immunodiagnostics segment is expected to dominate the market. Growth is driven by the expanded application of ELISA-linked tests and their ability to detect inactive or dormant viruses.

What are the factors expected to pose a challenge to market growth?

Challenges include the rising cost of veterinary diagnostic tests, lack of awareness about companion animal and livestock healthcare, and a shortage of veterinary healthcare professionals in emerging countries.

What is the expected market CAGR during the forecast period?

The veterinary diagnostics market is projected to grow at a CAGR of 7.8% during the forecast period (2025−2030).

TABLE OF CONTENTS

METHODOLOGY

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Veterinary Diagnostics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Veterinary Diagnostics Market

John

Jun, 2022

Which is the leading segment dominating the Veterinary Diagnostics Market?.

Jeremy

Jun, 2022

Can you give some more information on the key factors impacting the Veterinary Diagnostics Market?.

John

Jun, 2022

Which are the latest trends to focus for revenue expansion in Veterinary Diagnostics Market?.

DMCA.com Protection Status